Key result
Heart transplantation improves long-term survival and quality of life in refractory end-stage HF.
Why the study?
Heart failure prevalence is increasing and presents treatment challenges, prompting an analysis of current obstacles and perspectives surrounding heart transplantation in advanced heart failure.
Is heart transplantation a viable therapeutic alternative for patients with advanced heart failure?
Systematic Review
Is heart transplantation a viable therapeutic alternative for patients with advanced heart failure?
This systematic review confirms that heart transplantation remains a crucial therapeutic alternative for patients with end-stage heart failure refractory to conventional medical therapy.
Answers are grounded in this paper and cite their sources.
Heart transplantation offers a viable option for refractory HF; review leaves open questions on access, selection, and outcomes.
There are several diseases that affect the population worldwide, among the best known are those that are characterized by heart failure, a condition caused by a decrease in the function of the heart, where in many cases a transplant is required in the treatment. . The background of the study highlights the increase in the prevalence of heart failure and the challenges it presents in terms of its treatment. The main objective of this work is to analyze the current situation, obstacles and possible perspectives related to heart transplantation as a therapeutic alternative for patients with advanced heart failure. The methodology used consists of a systematic analysis of recent literature, focusing on different groups of patients. The review indicates that heart transplantation represents a promising option for patients with end-stage heart failure who do not respond to conventional treatments.
No takes yet. Share an insight, caveat, or question.
Yáñez et al. (2024) conducted a systematic review in Advanced heart failure. Heart transplant vs. Conventional treatments was evaluated on Survival and quality of life. Heart transplantation improves quality of life and long-term survival for patients with end-stage heart failure who do not respond to conventional treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: